Acute Myeloid Leukemia: To Treat or Not to Treat – Experience from a Resource-limited Setting
BACKGROUND: Acute myeloid leukemia (AML) is a group of hematologic malignancies characterized by proliferation of blasts of myeloid lineage in the bone marrow and or peripheral blood or tissues. Treatment outcome remains abysmal in our locality. OBJECTIVE: The aim was to determine the impact of trea...
Saved in:
| Main Authors: | Kaladada I. Korubo, Akpevwe Deborah Maduka, Emmanuel Wobo, Gracia Ekeh, Hannah E. Omunakwe, Linda Anucha Dublin-Green, Chijioke Adonye Nwauche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of Applied Hematology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/joah.joah_80_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
by: Mihee Kim, et al.
Published: (2024-12-01) -
Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)
by: L. A. Antipova, et al.
Published: (2022-11-01) -
Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
by: Dian Jin, et al.
Published: (2024-07-01) -
Efficacy and safety of mitoxantrone hydrochloride liposome-containing regimens in treating refractory/relapsed acute myeloid leukemia
by: Ni Lu, et al.
Published: (2025-05-01) -
Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01)